Spruce Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates Life Science Investing
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions Life Science Investing
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President Life Science Investing
BriaCell Adds Penn Medicine's Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study Biotech Investing
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference Life Science Investing
Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline Life Science Investing
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
